Shortly thereafter, more specific autoantibodies were discovered, including anti-GAD65, anti-IA2, insulin autoantibodies (IAAs), and, later, ZnT8 autoantibodies, each providing increasing resolution for diagnosing preclinical and overt T1DM [38,89]. This evidence concerns the gene INS and type 1 diabetes mellitus.